Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026)
Integer Holdings (ITGR) posted Cash from Financing Activities of $3.8 million for Q2 2026, up 106.21% sequentially from -$61.7 million in Q4 2025, and down 97.47% YoY from $151.6 million in Q2 2025.
Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Integer Holdings has reported Cash from Financing Activities for 17 years, with the latest figure at $3.8 million in Q2 2026.
- Quarterly Cash from Financing Activities fell 97.47% year-over-year to $3.8 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$104.2 million (down 6591.59% YoY) and the FY2025 annual result came in at $43.6 million, up 226.99% from the prior year.
- Cash from Financing Activities improved to $3.8 million in Q2 2026 per ITGR's latest filing, from -$61.7 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $163.3 million in Q1 2024 and troughed at -$82.3 million in Q4 2024.
- A 5-year average of $8.0 million and a median of -$10.7 million in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities jumped 3321.4% in 2023, then tumbled 569.69% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$13.9 million in 2022, then soared by 225.74% to $17.5 million in 2023, then sank by 569.69% to -$82.3 million in 2024, then advanced by 25.01% to -$61.7 million in 2025, then jumped by 106.21% to $3.8 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $3.8 million, -$61.7 million, and -$10.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Integer Holdings | 4.26 Bn | 4.24 Bn | 112.94 Mn | -23.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -23.59 Mn |
| Jul 3, 2026 | -23.59 Mn |
| Apr 3, 2026 | 3.83 Mn |
| Apr 3, 2026 | 3.83 Mn |
| Dec 31, 2025 | -61.72 Mn |
| Dec 31, 2025 | -61.72 Mn |
| Sep 26, 2025 | -10.71 Mn |
| Sep 26, 2025 | -10.71 Mn |
| Jun 27, 2025 | -35.59 Mn |
| Jun 27, 2025 | -35.59 Mn |
| Mar 28, 2025 | 151.58 Mn |
| Mar 28, 2025 | 151.58 Mn |
| Dec 31, 2024 | -82.30 Mn |
| Dec 31, 2024 | -82.30 Mn |
| Sep 27, 2024 | -43.14 Mn |
| Sep 27, 2024 | -43.14 Mn |
| Jun 28, 2024 | -24.53 Mn |
| Jun 28, 2024 | -24.53 Mn |
| Mar 29, 2024 | 163.29 Mn |
| Mar 29, 2024 | 163.29 Mn |